age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
50.44998
|
female
| 1
| 6
|
Coma
|
Coma
| 2
| null | null | 55
| 28,491
| null | null | 24
|
white
| 26.199219
| 50
| 0.520996
| 0.450989
| 1
| 1
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 3
| 63
| 28
| 160
| 30
| 40.89844
| 336.625
| null | 0.899902
| 0.799927
| 140
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 2.632813
| 6
| 1
|
72
|
female
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 40,390
| 21,526
| null | 12.5
|
black
| 15.5
| 15
| 0.885986
| 0.809937
| 1
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 13
| 83
| 8.898438
| 100
| 24
| 37
| 404.75
| null | 0.599976
| 0.899902
| 138
| 7.459961
| null | null | null | null | null | null | 2.584961
| 612
| 1
|
65.92999
|
female
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
| null | 0
| 60,355
| 30,505.6719
| null | 12.333328
|
white
| 21
| 29
| 0.809937
| 0.692993
| 1
| 1
| 0
|
yes
| 0.99
| 0.98
|
no dnr
| 16
| 63
| 7.099609
| 50
| 20
| 36.5
| null | null | null | 2.099609
| 140
| null | null | null | null | 2
| null | null | 1.839
| 1,336
| 0
|
69.77997
|
male
| 0
| 21
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 16
|
$25-$50k
| 0
| 117,036
| 59,274
| null | 22
|
white
| 22
| 27
| 0.822998
| 0.711914
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 21
| 57
| 8.699219
| 50
| 24
| 37
| 486.625
| 3.199707
| null | 1.299805
| 133
| 7.489258
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.812988
| 1,333
| 0
|
59.211
|
female
| 1
| 4
|
Lung Cancer
|
Cancer
| 3
| 14
|
>$50k
| 41
| 8,126
| 3,478.2188
| null | 20
|
white
| 18.898438
| 21
| 0.504883
| 0.18399
| 1
| 0
| 0
|
metastatic
| 0.01
| 0.000001
|
dnr after sadm
| 1
| 60
| 1.299805
| 90
| 20
| 37.19531
| null | null | null | 1.199951
| 127
| null | null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 4
| 1
|
32.27698
|
female
| 1
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 16
|
>$50k
| 0
| 175,267
| 79,371.5625
| null | 23.5
|
white
| 29.398438
| 35
| 0.517944
| 0.401978
| 19
| 0
| 0
|
yes
| 0.2
| 0.1
|
dnr after sadm
| 5
| 117
| 11.5
| 120
| 40
| 36
| 171.40625
| 2.399902
| 1.5
| 1.199951
| 134
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 2.416504
| 8
| 1
|
47.63898
|
female
| 0
| 9
|
Lung Cancer
|
Cancer
| 1
| 13
|
under $11k
| 0
| 13,877
| 7,902.1992
| null | 8
|
white
| 14.699219
| 16
| 0.785889
| 0.549927
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 9
| 77
| 1.199951
| 80
| 20
| 36.59375
| null | null | null | 0.799927
| 136
| null | null | null | null | 0
| null | null | 0.4948
| 723
| 1
|
74.26398
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
>$50k
| 0
| 35,636
| 17,422.5
| null | 18
|
white
| 31.5
| 37
| 0.628906
| 0.445984
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 10
| 40
| 6.799805
| 65
| 20
| 36.44531
| null | null | null | 1.5
| 131
| null | null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 41
| 1
|
71.29895
|
male
| 1
| 6
|
Coma
|
Coma
| 0
| 14
| null | 94
| 37,330
| 22,028.1719
| null | 29
|
white
| 21
| 23
| 0.257996
| 0.190979
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 3
| 62
| 21.699219
| 115
| 10
| 38.89844
| 317.125
| null | 0.5
| 1.099854
| 132
| 7.509766
| null | null | null | null | null |
<2 mo. follow-up
| 2.59082
| 6
| 1
|
78.05096
|
male
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
| null | 26
| 167,412
| 81,337.0625
| null | 28
|
white
| 29.5
| 44
| 0.347961
| 0.230988
| 10
| 0
| 0
|
yes
| null | null |
no dnr
| 26
| 52
| 8.398438
| 110
| 10
| 38.5
| 98.75
| null | null | 1.399902
| 141
| 7.529297
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,328
| 0
|
82.88599
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$11-$25k
| 0
| 8,568
| 4,712.4023
| null | 8
|
white
| 15.5
| 17
| 0.822998
| 0.711914
| 1
| 0
| 0
|
yes
| 0.65
| 0.5
|
no dnr
| 3
| 85
| 10.099609
| 65
| 16
| 36.5
| null | null | null | 1.099854
| 139
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,326
| 0
|
55.37
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$25-$50k
| 0
| 30,070
| 16,821.3906
| null | 13.5
|
white
| 22
| 31
| 0.86792
| 0.780884
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 80
| 6.799805
| 100
| 28
| 35.69531
| null | 4
| 4.099609
| 1.299805
| 132
| null | null | null | null | 1
| 4
|
no(M2 and SIP pres)
| 4
| 1,326
| 0
|
63.53198
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 188,077
| 97,198.875
| null | 16
|
other
| 20.796875
| 34
| 0.719971
| 0.633911
| 20
| 1
| 0
|
no
| null | null |
no dnr
| 19
| 138
| 6.799805
| 100
| 28
| 36.39844
| 254.28125
| null | null | 0.599976
| 136
| 7.489258
| null | null | null | null | null | null | 2.53125
| 1,323
| 0
|
72.32599
|
male
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 19
|
$25-$50k
| 9
| 21,341
| 13,080.7344
| null | 7
|
white
| 22.699219
| 43
| 0.61792
| 0.431946
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 8
| 71
| 4.599609
| 86
| 16
| 36.39844
| 423.75
| 3.299805
| 4
| 2.099609
| 133
| 7.489258
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 3.848633
| 71
| 1
|
50.64499
|
male
| 0
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$11-$25k
| 0
| 27,047
| 14,579.1094
| null | 10
|
white
| 19.597656
| 15
| 0.803955
| 0.68396
| 7
| 0
| 0
|
no
| 0.5
| 0.25
|
no dnr
| 4
| 77
| 10.898438
| 72
| 22
| 36.19531
| null | null | null | 1.299805
| 130
| null | null | null | null | 1
| null |
<2 mo. follow-up
| 1.1669
| 8
| 1
|
44.37
|
female
| 1
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 11
|
$11-$25k
| 55
| 88,231
| 43,843.0312
| null | 35
|
white
| 39.695313
| 69
| 0.202972
| 0.061996
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 8
| 102
| 38
| 70
| 32
| 36.39844
| 243
| 2.899902
| 42
| 6.799805
| 147
| 7.229492
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 8
| 1
|
52.75598
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 100
| 25,511
| 14,848.5469
| null | 25
|
white
| 48.898438
| 73
| 0.004999
| 0.001
| 1
| 1
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 3
| 38
| 15.398438
| 0
| 0
| 38.19531
| 186
| null | null | 0.799927
| 156
| 7.069336
| null | null | null | null | null |
<2 mo. follow-up
| 3.945313
| 3
| 1
|
63.27197
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 1
| null |
under $11k
| 0
| 11,532
| 6,581.8242
| null | 7.5
|
white
| 17.597656
| 15
| 0.699951
| 0.412964
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.512
|
dnr after sadm
| 4
| 101
| 8.199219
| 78
| 20
| 36
| null | null | null | 0.899902
| 131
| null | null | null | null | 1
| 5
| null | 5
| 60
| 1
|
68.20294
|
female
| 0
| 44
|
Colon Cancer
|
Cancer
| 2
| 14
|
under $11k
| 0
| 133,944
| 62,226.3438
| null | 22
|
white
| 21
| 21
| 0.747925
| 0.487
| 1
| 1
| 0
|
metastatic
| 0.95
| 0.8
|
no dnr
| 44
| 113
| 15.599609
| 108
| 28
| 37.19531
| null | null | 1.299805
| 0.799927
| 137
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 267
| 1
|
72.12598
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 41
| 127,395
| null | null | 25
|
white
| 25.796875
| 45
| 0.520996
| 0.404968
| 7
| 0
| 0
|
no
| null | null |
no dnr
| 8
| 113
| 13.298828
| 140
| 37
| 38
| 181.625
| null | null | 1
| 147
| 7.479492
| null | null | null | null | null | null | 4.060547
| 1,318
| 0
|
71.11298
|
female
| 1
| 4
|
Lung Cancer
|
Cancer
| 2
| 11
|
under $11k
| 41
| 9,606
| 4,738.4609
| null | 15
|
black
| 43.796875
| 65
| 0.003
| 0
| 1
| 1
| 0
|
metastatic
| 0.25
| 0.15
|
dnr after sadm
| 2
| 33
| 21.097656
| 124
| 32
| 36.79688
| 403.3125
| null | null | 2.099609
| 144
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 3.733887
| 4
| 1
|
63.836
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
>$50k
| 0
| 31,055
| 15,986.5625
| null | 15.5
|
white
| 22.796875
| 24
| 0.833984
| 0.728882
| 1
| 0
| 0
|
no
| 0.8
| 0.65
|
no dnr
| 9
| 70
| 14.798828
| 60
| 20
| 35.69531
| 186.65625
| null | null | 1.399902
| 136
| 7.299805
| null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 1,315
| 0
|
52.38599
|
male
| 0
| 12
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
| null | 0
| 140,565
| 64,369.125
| null | 26.5
|
white
| 36.296875
| 42
| 0.283997
| 0.174988
| 15
| 0
| 0
|
yes
| null | null |
no dnr
| 12
| 65
| 1
| 100
| 26
| 39.19531
| 122.4375
| null | 3.699707
| 0.799927
| 133
| 7.5
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.367676
| 1,315
| 0
|
86.04199
|
male
| 1
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 37
| 205,980
| 99,348.6875
| null | 36
|
white
| 26.796875
| 50
| 0.432983
| 0.312988
| 5
| 0
| 0
|
no
| null | null |
dnr after sadm
| 12
| 115
| 0.599976
| 110
| 12
| 36.89844
| 231.40625
| null | null | 1.199951
| 144
| 7.5
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 21
| 1
|
80.646
|
female
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 13
|
under $11k
| 0
| 34,235
| 21,265.7344
| null | 15
|
white
| 16.398438
| 22
| 0.85498
| 0.760986
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 16
| 80
| 7.5
| 60
| 22
| 36.39844
| 328.5625
| null | null | 1.299805
| 142
| 7.489258
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.243652
| 262
| 1
|
70.034
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
| null | 0
| 6,528
| 4,963.5117
| null | 8
|
white
| 21.296875
| 39
| 0.830933
| 0.724976
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 3
| 65
| 8.898438
| 85
| 18
| 35.89844
| null | null | null | 2.599609
| 136
| null | null | null | null | 2
| null |
no(M2 and SIP pres)
| 1.839
| 208
| 1
|
65.99896
|
female
| 0
| 27
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 11
| null | 0
| 53,190
| 27,477.9375
| null | 14
|
white
| 18.796875
| 28
| 0.775879
| 0.641968
| 1
| 0
| 0
|
no
| 0.5
| 0.1
|
no dnr
| 27
| 75
| 6.899414
| 96
| 24
| 38.19531
| null | 2.299805
| 2.699707
| 0.699951
| 131
| null | null | null | null | 5
| 5
|
SIP>=30
| 5
| 1,306
| 0
|
70.59296
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 12
| null | 0
| 17,079
| 11,626.0938
| null | 8
|
asian
| 34.296875
| 45
| 0.22699
| 0.024998
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 6
| 78
| 0.5
| 100
| 16
| 36.79688
| null | 2.5
| 5.199219
| 0.699951
| 132
| null | null | null | null | null | 4
|
no(M2 and SIP pres)
| 4
| 135
| 1
|
49.99597
|
female
| 1
| 87
|
Coma
|
Coma
| 0
| 14
|
under $11k
| 44
| 712,554
| null | null | 36
|
white
| 38.296875
| 60
| 0.125
| 0.078995
| 21
| 0
| 0
|
no
| null | null |
dnr after sadm
| 86
| 48
| 17.296875
| 140
| 44
| 39.79688
| 220
| null | 4.5
| 1.399902
| 151
| 7.429688
| null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 87
| 1
|
62.89899
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$11-$25k
| 0
| 12,826
| 8,660.6875
| null | 12
|
black
| 19.699219
| 26
| 0.870972
| 0.785889
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 6
| 75
| 5.699219
| 90
| 20
| 37
| 304.75
| null | null | 1.199951
| 126
| 7.439453
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.188477
| 1,305
| 0
|
55.87698
|
female
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| null | null | 26
| 55,987
| 93.8955
| null | 15.666664
|
white
| 19.898438
| 31
| 0.822998
| 0.712891
| 1
| 1
| 0
|
yes
| null | null |
dnr after sadm
| 2
| 63
| 11.798828
| 95
| 10
| 37.69531
| 187.5
| 3.699707
| 0.5
| 2
| 137
| 7.299805
| null | null | null | null | null | null | 3.985352
| 66
| 1
|
42.237
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
$25-$50k
| 0
| 41,885
| 22,365.5781
| null | 16
|
white
| 26.796875
| 29
| 0.805908
| 0.740967
| 6
| 0
| 0
|
no
| 0.15
| 0.05
|
no dnr
| 9
| 100
| 7.299805
| 82
| 24
| 35.19531
| 136.71875
| null | 5.199219
| 1.199951
| 137
| 7.439453
| null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 14
| 1
|
49.60999
|
female
| 0
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 14
|
>$50k
| 0
| 5,215
| 3,137.3457
| 3,357.18945
| 8
|
white
| 15.199219
| 34
| 0.889893
| 0.815918
| 1
| 0
| 0
|
no
| 0.9
| 0.74
|
no dnr
| 4
| 71
| 4.899414
| 64
| 22
| 36.39844
| null | 2.299805
| 1.5
| 1.099854
| 139
| null | 104
| 19
| 360
| 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,084
| 0
|
78.43695
|
female
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 9
| 34,499
| 18,041.7344
| 13,913.4531
| 14.333328
|
white
| 23.898438
| 27
| 0.695923
| 0.531982
| 1
| 0
| 0
|
no
| 0.4
| 0.2
|
dnr after sadm
| 2
| 63
| 14.798828
| 72
| 24
| 37.59375
| 157.125
| 3
| 0.399963
| 1.799805
| 140
| 7.339844
| 74
| 35
| 2,600
| null | 3
|
adl>=4 (>=5 if sur)
| 3
| 86
| 1
|
55.98599
|
male
| 1
| 27
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 18
|
>$50k
| 0
| 90,756
| 45,550.0625
| 57,981.3125
| 21.25
|
white
| 22.296875
| 25
| 0.862915
| 0.772949
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 27
| 80
| 8.5
| 74
| 20
| 35.59375
| 409.5
| 3.599609
| 1.699951
| 1.599854
| 128
| 7.5
| 141
| 31
| 1,875
| 0
| 0
|
<2 mo. follow-up
| 0
| 27
| 1
|
74.46698
|
female
| 1
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
$11-$25k
| 41
| 161,673
| 46,653.2188
| 57,038
| 37.666657
|
white
| 22
| 22
| 0.514893
| 0.397949
| 10
| 0
| 0
|
yes
| 0.75
| 0.75
|
dnr after sadm
| 15
| 118
| 9.599609
| 110
| 24
| 39.19531
| 280.9375
| 3.299805
| 0.299988
| 0.599976
| 130
| 7.549805
| 116
| 3
| 3,690
| null | 0
|
<2 mo. follow-up
| 0
| 16
| 1
|
44.90097
|
female
| 1
| 25
|
MOSF w/Malig
|
ARF/MOSF
| 4
| 14
|
>$50k
| 0
| 307,552
| 119,536.188
| 134,474.75
| 36.25
|
other
| 33.5
| 65
| 0.287964
| 0.177979
| 18
| 1
| 0
|
metastatic
| 0.75
| 0.5
|
dnr after sadm
| 23
| 62
| 16.898438
| 95
| 26
| 36.29688
| 125
| 3.399902
| 2.5
| 2.899902
| 144
| 7.479492
| 433
| 40
| 1,240
| null | 0
|
<2 mo. follow-up
| 0
| 25
| 1
|
44.383
|
male
| 0
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 20
|
>$50k
| 0
| 246,214
| 61,128.875
| 66,810.9375
| 30.5
|
white
| 21.296875
| 33
| 0.848999
| 0.797974
| 20
| 1
| 0
|
no
| 0.2
| 0.1
|
no dnr
| 29
| 65
| 7.099609
| 80
| 26
| 36.5
| 300
| null | 0.799927
| 2.699707
| 145
| 7.489258
| 139
| 29
| 5,040
| null | null | null | 2.456055
| 109
| 1
|
26.51299
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 17
|
under $11k
| 26
| 87,124
| 28,491.8594
| 88,260.25
| 29.5
|
hispanic
| 34.695313
| 47
| 0.643921
| 0.542969
| 6
| 0
| 0
|
no
| null | null |
no dnr
| 13
| 113
| 19
| 135
| 44
| 38.39844
| 95.375
| null | 2.5
| 0.699951
| 133
| 7.5
| 114
| 7
| 6,500
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,079
| 0
|
70.90796
|
male
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 9
| 390,845
| 51,077.6875
| 54,144.125
| 36.666657
|
white
| 37.695313
| 71
| 0.29895
| 0.187988
| 32
| 0
| 0
|
no
| 0.01
| 0.01
|
dnr after sadm
| 1
| 50
| 26.199219
| 120
| 28
| 38.69531
| 392.5625
| null | 5.5
| 2.199707
| 133
| 7.509766
| 213
| 65
| 5,880
| null | null |
<2 mo. follow-up
| 3.464356
| 18
| 1
|
63.64697
|
male
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
| null | 0
| 142,625
| 60,269.375
| 205,850.25
| 42.333313
|
white
| 16.796875
| 37
| 0.861938
| 0.814941
| 1
| 0
| 0
|
yes
| 0.75
| 0.6
|
no dnr
| 23
| 65
| 7.099609
| 55
| 21
| 37.69531
| 237.125
| 2.199707
| 2.299805
| 0.799927
| 137
| 7.459961
| 215
| 12
| 5,605
| null | 6
|
adl>=4 (>=5 if sur)
| 6
| 157
| 1
|
72.54797
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 0
| null | null | 0
| 10,862
| 5,092.5898
| 7,937.4375
| 19
|
asian
| 15.798828
| 12
| 0.819946
| 0.611938
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
no dnr
| 5
| 69
| 5.199219
| 72
| 20
| 36.39844
| null | 3.299805
| 0.199982
| 1.099854
| 138
| null | null | 13
| 2,125
| null | null | null | 1.832031
| 354
| 1
|
81.24298
|
male
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 14
| null | 44
| 172,335
| 78,254
| 88,530.5
| 35.75
|
white
| 31
| 42
| 0.377991
| 0.259949
| 1
| 0
| 0
|
no
| 0.3
| 0.3
|
no dnr
| 26
| 60
| 14.5
| 110
| 12
| 38.69531
| 92
| 2.5
| 1.399902
| 1.399902
| 130
| 7.5
| 106
| 23
| 5,075
| null | 2
|
no(M2 and SIP pres)
| 2
| 1,076
| 0
|
34.59299
|
male
| 1
| 13
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 17
|
under $11k
| 0
| 118,073
| 45,941.9375
| 119,265.875
| 38
|
white
| 29.199219
| 33
| 0.527954
| 0.412964
| 2
| 0
| 0
|
metastatic
| 0.6
| 0.3
|
dnr after sadm
| 7
| 97
| 21.5
| 146
| 32
| 39
| 280.9375
| null | null | 0.599976
| 127
| 7.5
| 119
| 6
| 2,159
| null | 7
|
<2 mo. follow-up
| 7
| 13
| 1
|
61.39398
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$11-$25k
| 0
| 54,893
| 23,850.4531
| 28,051.6875
| 31.5
|
white
| 23.5
| 25
| 0.832886
| 0.726929
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 11
| 75
| 9.798828
| 65
| 20
| 36
| null | null | 1.599854
| 1.799805
| 129
| null | 80
| 63
| 2,375
| null | 2
|
<2 mo. follow-up
| 2
| 20
| 1
|
76.05499
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 14
| null | 0
| 7,626
| 4,572.4883
| 4,176.71875
| 9
|
white
| 20
| 25
| 0.784912
| 0.654907
| 1
| 0
| 1
|
yes
| 0.6
| 0.5
|
no dnr
| 4
| 101
| 6.799805
| 114
| 20
| 36.79688
| null | null | 0.599976
| 1.699951
| 139
| null | 161
| 39
| 2,390
| 6
| null |
no(M2 and SIP pres)
| 4.527344
| 1,070
| 0
|
49.49197
|
female
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
>$50k
| 0
| 177,889
| 56,882.1562
| 159,476.75
| 30
|
white
| 31.5
| 43
| 0.689941
| 0.5979
| 7
| 0
| 0
|
no
| 0.85
| 0.85
|
no dnr
| 26
| 105
| 13
| 110
| 30
| 39.29688
| 105
| 4.5
| null | 0.599976
| 147
| 7.469727
| 105
| 25
| 1,480
| null | 7
|
no(M2 and SIP pres)
| 7
| 1,067
| 0
|
78.03699
|
male
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 35,566
| 19,382.1406
| 14,667.875
| 20.666656
|
white
| 24.699219
| 41
| 0.689941
| 0.523926
| 1
| 0
| 0
|
yes
| 0.5
| 0.25
|
dnr after sadm
| 1
| 75
| 36.09375
| 70
| 22
| 36
| 414.25
| null | null | 2.5
| 135
| 7.489258
| 90
| 71
| 650
| 5
| null | null | 3.854981
| 74
| 1
|
54.02298
|
female
| 1
| 46
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 10
| null | 89
| 676,210
| 179,056.875
| 200,250.125
| 40.5
|
white
| 36.296875
| 77
| 0.084991
| 0.032997
| 39
| 0
| 0
|
no
| null | null |
no dnr
| 46
| 55
| 12.898438
| 115
| 46
| 39.19531
| 290
| 3.299805
| 4.599609
| 3.799805
| 143
| 7.439453
| 74
| 95
| 160
| null | 0
|
<2 mo. follow-up
| 0
| 46
| 1
|
85.10297
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 9
| 62,841
| 21,997.9062
| 25,121.2969
| 14.333328
|
white
| 29.796875
| 34
| 0.495972
| 0.377991
| 5
| 1
| 0
|
no
| 0.9
| 0.8
|
dnr before sadm
| -4
| 73
| 10.099609
| 105
| 24
| 38
| 83.32812
| null | null | 1.199951
| 128
| 7.469727
| 353
| 20
| 2,978
| 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,065
| 0
|
52.02197
|
male
| 0
| 52
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 16
|
$11-$25k
| 26
| 593,198
| 174,370.625
| 200,240.375
| 31.75
|
hispanic
| 24.898438
| 42
| 0.684937
| 0.591919
| 33
| 0
| 0
|
no
| null | null |
no dnr
| 52
| 108
| 3.799805
| 55
| 32
| 38.39844
| 418.3125
| null | 3.599609
| 1.5
| 145
| 7.419922
| 332
| 81
| 1,760
| null | 7
|
no(M2 and SIP pres)
| 7
| 1,063
| 0
|
86.62799
|
male
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 26
| 96,480
| 25,141.3281
| 110,968.812
| 25.333328
|
white
| 25.296875
| 27
| 0.501953
| 0.383972
| 9
| 0
| 0
|
no
| null | null |
no dnr
| 20
| 98
| 28.898438
| 75
| 36
| 36.39844
| 142
| null | null | 1
| 150
| 7.519531
| 357
| 16
| null | null | 0
| null | 0
| 1,061
| 0
|
58.95398
|
female
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 0
| 298,234
| 39,437.875
| 49,378.625
| 34.5
|
white
| 32.398438
| 56
| 0.570923
| 0.459961
| 71
| 0
| 0
|
no
| 0.1
| 0.1
|
no dnr
| 11
| 135
| 5.599609
| 95
| 10
| 39.09375
| 170
| null | 18.898438
| 1.5
| 153
| 7.439453
| 182
| 76
| 1,880
| null | null |
<2 mo. follow-up
| 3.206543
| 11
| 1
|
57.69699
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 12,827
| 5,347.5469
| 5,639.44922
| 7
|
white
| 16.097656
| 10
| 0.741943
| 0.47699
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 4
| 112
| 11.699219
| 80
| 16
| 37
| null | 3.299805
| 0.299988
| 1
| 141
| null | 94
| 14
| 6,360
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 320
| 1
|
59.44397
|
male
| 1
| 18
|
Coma
|
Coma
| 1
| 24
|
>$50k
| 0
| 223,643
| 93,965.8125
| 154,506.25
| 54
|
white
| 20.5
| 33
| 0.784912
| 0.743896
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 17
| 142
| 19.296875
| 115
| 8
| 38.79688
| 317.75
| null | 1.899902
| 1.099854
| 144
| 7.509766
| 393
| 33
| 3,050
| null | 0
|
<2 mo. follow-up
| 0
| 18
| 1
|
37.74698
|
male
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 16
|
$25-$50k
| 89
| 577,381
| 99,014.5
| 111,047.625
| 57
|
white
| 35.695313
| 83
| 0.18399
| 0.095993
| 28
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 13
| 62
| 9.199219
| 145
| 12
| 37.89844
| 280
| 4.899414
| 32.695313
| 2.599609
| 138
| 7.489258
| 129
| 71
| 12
| null | 3
|
<2 mo. follow-up
| 3
| 13
| 1
|
52.99698
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
>$50k
| 100
| 174,687
| 14,567.3828
| 17,020.0156
| 47
|
white
| 43.398438
| 74
| 0.011999
| 0.002
| 8
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 3
| 42
| 6.799805
| 105
| 29
| 35.5
| 307.5
| null | 6.399414
| 8
| 145
| 7.389648
| 658
| 98
| 0
| null | null |
<2 mo. follow-up
| 3.782715
| 3
| 1
|
76.28497
|
male
| 0
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
>$50k
| 0
| 141,756
| 64,223.875
| 63,816.7188
| 31
|
white
| 34.195313
| 58
| 0.459961
| 0.340942
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 35
| 72
| 6.299805
| 180
| 10
| 36.79688
| 64
| 2
| null | 0.799927
| 129
| 7.5
| 165
| 26
| 3,450
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 1,060
| 0
|
57.53
|
female
| 0
| 53
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
$25-$50k
| 41
| 261,184
| 121,786.438
| 115,827.938
| 29
|
white
| 33.5
| 58
| 0.399963
| 0.280945
| 1
| 1
| 0
|
yes
| 0.5
| 0.7
|
no dnr
| 53
| 58
| 17.5
| 130
| 12
| 38.5
| 325.6875
| 2.599609
| 0.5
| 4.099609
| 125
| 7.429688
| 841
| 66
| 895
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 1,059
| 0
|
70.20398
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 10
|
$25-$50k
| 0
| 10,586
| 3,956.8867
| 4,522.85938
| 13
|
white
| 13.798828
| 10
| 0.756958
| 0.500977
| 1
| 0
| 0
|
metastatic
| 1
| 0.5
|
no dnr
| 4
| 123
| null | 78
| 18
| 36.79688
| null | null | null | 0.899902
| 137
| null | null | 5
| 5,170
| 0
| 0
|
SIP>=30
| 0
| 245
| 1
|
66.04498
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 13
|
>$50k
| 0
| 11,532
| 4,416.3945
| 4,909.53906
| 13
|
white
| 16.398438
| 12
| 0.717896
| 0.439941
| 1
| 0
| 0
|
metastatic
| 1
| 0.5
|
no dnr
| 4
| 79
| 11.5
| 80
| 16
| 36.79688
| null | null | null | 1.399902
| 135
| null | null | 15
| 5,250
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 385
| 1
|
42.69397
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 76,504
| 28,285.4219
| 29,885.0625
| 37.5
|
white
| 28.699219
| 27
| 0.792969
| 0.724976
| 3
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 11
| 103
| 2.399902
| 125
| 26
| 39.29688
| 286.625
| 2.5
| 0.5
| 1
| 130
| 7.449219
| 123
| 12
| 2,000
| null | null | null | 3.315918
| 1,058
| 0
|
44.23297
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
| null | 0
| 78,031
| 17,341.1094
| 19,316.0156
| 15
|
hispanic
| 25.796875
| 39
| 0.80896
| 0.745972
| 7
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 7
| 72
| 19.199219
| 75
| 36
| 38.89844
| 136.71875
| 2.5
| 3.799805
| 1.299805
| 143
| 7.459961
| 101
| 26
| 4,005
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,057
| 0
|
49.892
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
under $11k
| 0
| 36,044
| 13,711.9844
| 16,086.1641
| 14.5
|
white
| 31.5
| 55
| 0.652954
| 0.553955
| 3
| 0
| 0
|
yes
| 0
| 0
|
no dnr
| 7
| 70
| 2.299805
| 125
| 35
| 37.89844
| null | null | null | 2.5
| 140
| null | null | 52
| 1,350
| null | 3
|
<2 mo. follow-up
| 3
| 7
| 1
|
20.523
|
male
| 0
| 52
|
MOSF w/Malig
|
ARF/MOSF
| 4
| null |
$11-$25k
| 0
| 784,726
| 180,566
| 189,590.375
| 34.25
|
other
| 34.5
| 57
| 0.370972
| 0.252991
| 88
| 1
| 0
|
yes
| 0.5
| 0.5
|
dnr after sadm
| 52
| 110
| 0.049995
| 118
| 32
| 36.79688
| 236.65625
| null | 5.5
| 0.799927
| 142
| 7.439453
| 251
| 30
| 3,890
| null | 6
| null | 6
| 66
| 1
|
62.5
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 9
|
under $11k
| 0
| 10,163
| 4,479.3477
| 4,604.37891
| 16
|
white
| 11.898438
| 10
| 0.799927
| 0.574951
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.8
|
no dnr
| 4
| 113
| 6.5
| 80
| 20
| 36
| null | 3.799805
| null | 0.899902
| 138
| null | 194
| 9
| 5,700
| 5
| null |
no(M2 and SIP pres)
| 3.854981
| 229
| 1
|
37.47598
|
male
| 1
| 57
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 9
|
$11-$25k
| 0
| 270,127
| 120,381.812
| 127,205.188
| 22.75
|
hispanic
| 21.699219
| 26
| 0.911987
| 0.850952
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 57
| 71
| 14.599609
| 55
| 16
| 37.09375
| null | null | 2.599609
| 1.299805
| 131
| null | 99
| 33
| 4,275
| 1
| 0
|
<2 mo. follow-up
| 0
| 57
| 1
|
59.45499
|
female
| 0
| 91
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
|
>$50k
| 0
| 976,623
| 320,064.75
| 374,988.5
| 33
|
white
| 29.199219
| 57
| 0.656982
| 0.55896
| 26
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 91
| 73
| 4.799805
| 115
| 30
| 38.59375
| 312.5
| 4.599609
| 1.599854
| 3.699707
| 142
| 7.379883
| null | 75
| 238
| null | 2
|
adl>=4 (>=5 if sur)
| 2
| 205
| 1
|
66.26099
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| null | null | 26
| 11,494
| 6,642.3359
| 6,104.63672
| 8.5
|
black
| 13.398438
| 22
| 0.810913
| 0.69397
| 1
| 1
| 0
|
metastatic
| 0.85
| 0.5
|
no dnr
| 7
| 110
| 9.599609
| 109
| 20
| 36
| 442.8125
| 4.599609
| 0.899902
| 1.299805
| 137
| 7.469727
| 251
| 23
| 3,420
| null | null | null | 4.881836
| 87
| 1
|
59.03598
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 20
|
>$50k
| 0
| 21,359
| 10,872.9297
| 11,947.6094
| 19.5
|
white
| 34
| 51
| 0.665894
| 0.491943
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 49
| 7.099609
| 120
| 16
| 36.39844
| null | null | null | 2.899902
| 132
| null | 100
| 43
| 1,770
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,055
| 0
|
60.271
|
male
| 1
| 55
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
|
$25-$50k
| 0
| 460,668
| 190,896.5
| 216,081.625
| 33.25
|
white
| 20.296875
| 32
| 0.830933
| 0.773926
| 1
| 0
| 0
|
yes
| 0.9
| 0.6
|
dnr after sadm
| 37
| 115
| 7.799805
| 120
| 20
| 36.89844
| null | null | null | 1.699951
| 143
| null | 154
| 85
| 2,850
| null | 3
|
<2 mo. follow-up
| 3
| 55
| 1
|
20.99699
|
male
| 1
| 3
|
Coma
|
Coma
| 3
| 14
|
under $11k
| 100
| 278,242
| 24,999.6562
| 20,352.4219
| 45
|
asian
| 47.796875
| 92
| 0.003
| 0.001
| 40
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 1
| 60
| 27.5
| 85
| 24
| 35
| 54
| 2.399902
| 20.597656
| 4.099609
| 150
| 6.939453
| 335
| 75
| 110
| null | null |
<2 mo. follow-up
| 3.309082
| 3
| 1
|
55.655
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 26
| 34,920
| 19,289.2969
| 20,270.2656
| 20.5
|
white
| 24.5
| 43
| 0.762939
| 0.687988
| 1
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 12
| 75
| 8.298828
| 116
| 8
| 36.59375
| 419
| 3.699707
| 0.199982
| 2
| 154
| 7.549805
| 111
| 63
| 2,030
| null | 5
|
adl>=4 (>=5 if sur)
| 5
| 1,053
| 0
|
45.43698
|
female
| 0
| 93
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 636,886
| null | null | 40.25
|
white
| 38.398438
| 75
| 0.50293
| 0.385986
| 1
| 0
| 0
|
no
| 0.4
| 0.5
|
no dnr
| 93
| 107
| 0.199982
| 140
| 40
| 37.89844
| 178
| null | 3
| 0.5
| 134
| 7.299805
| null | 23
| 2,050
| null | null | null | 2.833008
| 1,053
| 0
|
49.92499
|
male
| 0
| 14
|
Colon Cancer
|
Cancer
| 1
| 17
|
>$50k
| 0
| 23,578
| 12,864.6016
| 14,080.5859
| 7.333332
|
white
| 20.097656
| 18
| 0.802979
| 0.579956
| 1
| 0
| 0
|
metastatic
| 1
| 0.5
|
no dnr
| 14
| 70
| 11.099609
| 120
| 20
| 39.59375
| null | null | null | null | 140
| null | null | null | 3,450
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 935
| 1
|
42.11899
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
| null | 26
| 1,086,011
| 48,990.7812
| 62,284.125
| 29
|
hispanic
| 30.097656
| 56
| 0.608887
| 0.50293
| 147
| 0
| 0
|
no
| null | null |
no dnr
| 23
| 72
| 3.899902
| 115
| 28
| 38.19531
| 311.0625
| null | 1.599854
| 2.899902
| 147
| 7.449219
| 78
| 64
| 151
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,050
| 0
|
75.08795
|
male
| 1
| 4
|
Coma
|
Coma
| 4
| null | null | 100
| 157,000
| 22,982.7031
| 25,227.9062
| 51
|
white
| 52.09375
| 116
| 0
| 0
| 17
| 1
| 0
|
yes
| null | null |
no dnr
| 4
| 32
| 0.049995
| 155
| 26
| 38.5
| 126.25
| null | null | 4.599609
| 153
| 7.239258
| 67
| 112
| 0
| null | null |
<2 mo. follow-up
| 3.80957
| 4
| 1
|
44.32599
|
male
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
under $11k
| 0
| 44,950
| 23,775.2188
| 24,613.2969
| 14.333328
|
black
| 32.398438
| 40
| 0.772949
| 0.637939
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 15
| 73
| 4.899414
| 95
| 26
| 37.5
| null | 2.099609
| 0.299988
| 2.599609
| 129
| null | 154
| 51
| 2,650
| 0
| 0
|
SIP>=30
| 0
| 526
| 1
|
75.17896
|
male
| 0
| 47
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 15
| null | 26
| 191,750
| 67,892.75
| 66,681.9375
| 28.75
|
white
| 24.5
| 47
| 0.526978
| 0.411987
| 7
| 1
| 0
|
yes
| 0.5
| 0.95
|
no dnr
| 47
| 72
| 8
| 100
| 26
| 37.69531
| 172.5
| null | null | 6.199219
| 142
| 7.449219
| 267
| 78
| 935
| null | 0
| null | 0
| 1,049
| 0
|
51.452
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 10,606
| 5,724.3086
| 6,900.46875
| 17
|
white
| 15
| 12
| 0.772949
| 0.527954
| 1
| 0
| 0
|
metastatic
| 1
| 0.9
|
no dnr
| 6
| 73
| 3.399902
| 80
| 20
| 36.19531
| null | null | 0.099991
| 0.699951
| 138
| null | null | 8
| 6,150
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 434
| 1
|
62.37598
|
male
| 1
| 14
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 18
|
>$50k
| 0
| 139,026
| 47,879.5938
| 53,606.2812
| 29.666656
|
black
| 41.695313
| 71
| 0.132996
| 0.060997
| 12
| 0
| 0
|
yes
| 0.5
| 0.25
|
dnr after sadm
| 11
| 108
| 5.399414
| 70
| 12
| 35.89844
| 153.03125
| 2.299805
| 9.599609
| 5.199219
| 127
| 7.419922
| 186
| 101
| 1,131
| null | 4
|
<2 mo. follow-up
| 4
| 14
| 1
|
54.47498
|
male
| 0
| 25
|
Lung Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 94,914
| 44,798.6562
| 55,629.2812
| 15.75
|
white
| 6.299805
| 6
| 0.87793
| 0.723999
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 25
| 97
| 6
| 76
| 20
| 36.19531
| null | 4.099609
| 0.5
| 1.099854
| 138
| null | 165
| 12
| 7,500
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,048
| 0
|
52.62997
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 12,265
| 7,544.2812
| 8,521.5625
| 10
|
white
| 13.099609
| 23
| 0.878906
| 0.726929
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 5
| 101
| 10
| 80
| 22
| 37.79688
| null | 3.799805
| 0.399963
| 1.099854
| 132
| null | 114
| 20
| 1,075
| null | null |
no(M2 and SIP pres)
| 1.857666
| 838
| 1
|
75.77496
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 13
| null | 0
| 10,782
| 6,787.6914
| 6,076.12891
| 15
|
white
| 17.199219
| 9
| 0.859985
| 0.768921
| 1
| 0
| 0
|
no
| 0.98
| 0.9
|
no dnr
| 6
| 108
| 10.699219
| 95
| 22
| 36.39844
| null | null | null | 0.899902
| 137
| null | null | 15
| 3,450
| 0
| null | null | 0.494751
| 716
| 1
|
76.961
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 0
| 88,755
| 37,615.1875
| 40,109.4375
| 32.333313
|
hispanic
| 28
| 34
| 0.642944
| 0.541992
| 4
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 17
| 78
| 9.099609
| 105
| 12
| 36.5
| 440
| null | null | 2
| 126
| 7.439453
| 159
| 30
| 7,219
| null | 3
|
adl>=4 (>=5 if sur)
| 3
| 1,045
| 0
|
54.71597
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 14
|
$25-$50k
| 0
| 31,403
| 15,863.2109
| 15,708.2656
| 20
|
white
| 28.097656
| 53
| 0.782959
| 0.712891
| 1
| 1
| 0
|
no
| 0.3
| 0.25
|
no dnr
| 10
| 100
| 26.296875
| 75
| 15
| 38
| 108.32812
| 2.399902
| 1.399902
| 2.199707
| 132
| 7.369141
| 119
| 56
| 970
| 2
| 2
| null | 2
| 1,045
| 0
|
79.70398
|
female
| 1
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 5
| 16
|
$11-$25k
| 0
| 56,752
| 24,689.4531
| 31,170.0625
| 33.5
|
white
| 33.5
| 38
| 0.428955
| 0.309998
| 1
| 1
| 0
|
yes
| 0.5
| 0.3
|
dnr after sadm
| 9
| 60
| 22
| 110
| 36
| 36.09375
| 108
| 2.599609
| null | 0.5
| 135
| 7.459961
| null | 16
| 1,870
| null | null |
<2 mo. follow-up
| 3.677246
| 11
| 1
|
53.36099
|
male
| 1
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 18
|
under $11k
| 0
| 314,092
| 84,356.8125
| 90,715.5625
| 36
|
white
| 28.796875
| 40
| 0.724976
| 0.639893
| 7
| 0
| 0
|
no
| null | null |
dnr after sadm
| 22
| 97
| 11.599609
| 70
| 32
| 36.79688
| 313.3125
| 3.099609
| 7.799805
| 2.699707
| 140
| 7.419922
| 286
| 96
| 7,660
| null | 0
|
<2 mo. follow-up
| 0
| 22
| 1
|
73.94897
|
male
| 0
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 44
| 208,988
| 79,771.75
| 95,195.1875
| 45.25
|
asian
| 31.199219
| 54
| 0.334961
| 0.218994
| 1
| 1
| 0
|
yes
| 0.15
| 0.05
|
dnr after sadm
| 8
| 62
| 6.199219
| 115
| 30
| 38
| 127.5
| null | 0.399963
| 2.699707
| 135
| 7.509766
| 160
| 64
| 5,055
| null | null |
<2 mo. follow-up
| 3.924316
| 57
| 1
|
21.20999
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null |
under $11k
| 37
| 73,268
| 28,876.6094
| 37,257.7812
| 27.5
|
hispanic
| 27.097656
| 57
| 0.804932
| 0.73999
| 2
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 8
| 112
| 7.199219
| 120
| 26
| 38.69531
| 291.375
| 1.599854
| 13.798828
| 0.699951
| 140
| 7.459961
| null | 9
| 1,325
| null | 1
|
<2 mo. follow-up
| 1
| 8
| 1
|
86.35199
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$11-$25k
| 44
| 125,804
| 11,069.0859
| 12,813.4297
| 31
|
white
| 42.296875
| 70
| 0.028
| 0.007
| 10
| 0
| 0
|
no
| 0.25
| 0.25
|
dnr before sadm
| -3
| 45
| 23.5
| 75
| 36
| 36.19531
| 97
| 2.799805
| null | 2
| 131
| 7.379883
| 310
| 60
| 1,262
| null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
33.55197
|
male
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 26,882
| 12,281.9531
| 13,067.7891
| 24
|
black
| 23.699219
| 27
| 0.892944
| 0.85498
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 113
| 15.699219
| 125
| 28
| 39.29688
| 348.5625
| null | null | 1
| 133
| 7.429688
| 69
| 6
| 2,060
| null | null |
no(M2 and SIP pres)
| 3.226563
| 442
| 1
|
64.58295
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 12
|
$25-$50k
| 0
| 5,751
| 3,211.9102
| 23,493.7031
| 5
|
white
| 13.298828
| 5
| 0.775879
| 0.533936
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 81
| 5.699219
| 84
| 20
| 37.79688
| null | null | null | 0.799927
| 140
| null | 92
| 11
| 2,775
| null | 0
| null | 0
| 155
| 1
|
79.54596
|
female
| 0
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 44
| 30,631
| 13,084.1094
| 17,486.9062
| 42
|
white
| 24.398438
| 34
| 0.576904
| 0.465942
| 1
| 1
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 5
| 60
| 15.398438
| 25
| 32
| 38.29688
| null | 3
| null | 0.699951
| 146
| null | 189
| 11
| 422
| null | null | null | 3.564941
| 580
| 1
|
67.71497
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
>$50k
| 0
| 46,447
| 10,272.25
| 12,649.1328
| 14.5
|
white
| 23.597656
| 25
| 0.771973
| 0.697998
| 4
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 7
| 72
| 8.798828
| 72
| 22
| 36.5
| 83.32812
| 2.399902
| 0.699951
| 0.899902
| 133
| 7.539062
| 95
| 11
| 2,050
| 2
| null |
no(M2 and SIP pres)
| 1.838867
| 1,036
| 0
|
48.73599
|
female
| 0
| 26
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 117,616
| 50,040.3438
| 57,753.0625
| 12
|
white
| 14.5
| 12
| 0.785889
| 0.550903
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 26
| 73
| 5
| 96
| 24
| 37.5
| null | null | 0.199982
| 0.899902
| 135
| null | 88
| 9
| 4,735
| null | null | null | 3.026856
| 314
| 1
|
63.79498
|
female
| 0
| 8
|
Lung Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 11,253
| 7,390.0273
| 8,001.83984
| 9
|
white
| 11.5
| 13
| 0.803955
| 0.582886
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 8
| 101
| 6.399414
| 120
| 24
| 36.19531
| null | 4.199219
| 0.399963
| 0.899902
| 140
| null | 79
| null | 2,200
| 4
| null |
adl>=4 (>=5 if sur)
| 3.183106
| 68
| 1
|
88.422
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 111,560
| 36,010.375
| 35,541.2812
| 14.666664
|
white
| 27.199219
| 56
| 0.439941
| 0.320984
| 8
| 0
| 1
|
no
| null | null |
no dnr
| 17
| 72
| 17.199219
| 145
| 36
| 38.69531
| 148.3125
| 2.699707
| 0.399963
| 1.099854
| 146
| 7.479492
| 131
| 21
| 1,975
| null | null | null | 6.273438
| 930
| 1
|
54.38199
|
male
| 1
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 13
|
$11-$25k
| 44
| 508,881
| 77,303.1875
| 88,043.3125
| 48
|
white
| 38.398438
| 60
| 0.141998
| 0.066986
| 35
| 0
| 0
|
yes
| 0.7
| 0.7
|
dnr after sadm
| 16
| 117
| 5.099609
| 45
| 27
| 38
| 265
| 3.799805
| 29.5
| 4.899414
| 144
| 7.429688
| 140
| 99
| 619
| null | 2
|
<2 mo. follow-up
| 2
| 16
| 1
|
63.62198
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 14
| null | 0
| 36,522
| 18,165.5312
| 22,120.875
| 22.5
|
white
| 31.597656
| 24
| 0.691895
| 0.525879
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 9
| 45
| 12
| 115
| 16
| 36.59375
| null | null | null | 1
| 131
| null | 106
| 16
| 2,960
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,027
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.